Agile Therapeutics Free Cash Flow 2013-2023 | AGRX
Agile Therapeutics free cash flow from 2013 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Agile Therapeutics Annual Free Cash Flow |
| 2023 |
-9.58 |
| 2022 |
-36.08 |
| 2021 |
-65.47 |
| 2020 |
-47.66 |
| 2019 |
-15.79 |
| 2018 |
-17.21 |
| 2017 |
-25.87 |
| 2016 |
-23.33 |
| 2015 |
-25.77 |
| 2014 |
-14.60 |
| 2013 |
-17.96 |
| 2012 |
-29.66 |
| Agile Therapeutics Quarterly Free Cash Flow |
| 2023-12-31 |
-9.58 |
| 2023-09-30 |
-9.75 |
| 2023-06-30 |
-10.11 |
| 2023-03-31 |
-1.60 |
| 2022-12-31 |
-36.08 |
| 2022-09-30 |
-34.52 |
| 2022-06-30 |
-17.82 |
| 2022-03-31 |
-14.88 |
| 2021-12-31 |
-65.47 |
| 2021-09-30 |
-48.80 |
| 2021-06-30 |
-30.15 |
| 2021-03-31 |
-14.74 |
| 2020-12-31 |
-47.66 |
| 2020-09-30 |
-30.27 |
| 2020-06-30 |
-14.87 |
| 2020-03-31 |
-8.05 |
| 2019-12-31 |
-15.79 |
| 2019-09-30 |
-12.45 |
| 2019-06-30 |
-7.34 |
| 2019-03-31 |
-4.96 |
| 2018-12-31 |
-17.21 |
| 2018-09-30 |
-14.08 |
| 2018-06-30 |
-10.22 |
| 2018-03-31 |
-5.99 |
| 2017-12-31 |
-25.87 |
| 2017-09-30 |
-19.52 |
| 2017-06-30 |
-12.37 |
| 2017-03-31 |
-6.01 |
| 2016-12-31 |
-23.33 |
| 2016-09-30 |
-20.41 |
| 2016-06-30 |
-13.02 |
| 2016-03-31 |
-6.74 |
| 2015-12-31 |
-25.77 |
| 2015-09-30 |
-20.70 |
| 2015-06-30 |
-13.47 |
| 2015-03-31 |
-5.84 |
| 2014-12-31 |
-14.60 |
| 2014-09-30 |
-9.03 |
| 2014-06-30 |
-1.22 |
| 2014-03-31 |
0.93 |
| 2013-12-31 |
|
| 2013-09-30 |
-16.07 |
| 2013-06-30 |
-11.82 |
| 2012-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
|
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|
